{"id":86619,"date":"2021-03-23T06:56:49","date_gmt":"2021-03-23T06:56:49","guid":{"rendered":"https:\/\/www.alj.com\/news\/evelo-biosciences-abdul-latif-jameel-health-announce-strategic-collaboration-to-develop-commercialize-novel-therapy-edp1815-for-inflammatory-diseases-covid-19-in-select-developing-markets-servin\/"},"modified":"2023-03-28T09:07:04","modified_gmt":"2023-03-28T09:07:04","slug":"evelo-biosciences-abdul-latif-jameel-health-announce-strategic-collaboration-to-develop-commercialize-novel-therapy-edp1815-for-inflammatory-diseases-covid-19-in-select-developing-markets-servin","status":"publish","type":"news","link":"https:\/\/alj.com\/tr\/news\/evelo-biosciences-abdul-latif-jameel-health-announce-strategic-collaboration-to-develop-commercialize-novel-therapy-edp1815-for-inflammatory-diseases-covid-19-in-select-developing-markets-servin\/","title":{"rendered":"Evelo Biosciences ve Abdul Latif Jameel Health\u2019ten 1,7 Milyar \u0130nsana Hizmet Eden Orta Do\u011fu, T\u00fcrkiye ve Afrika Pazarlar\u0131nda Enflamatuar Hastal\u0131klar ve COVID-19 i\u00e7in Stratejik \u0130\u015f birli\u011fi"},"content":{"rendered":"<ul>\n<li>ABD merkezli biyoteknoloji \u015firketi Evelo Biosciences ve Orta Do\u011fu, Kuzey Afrika ve T\u00fcrkiye\u2019de (MENAT b\u00f6lgesi) modern t\u0131bbi bak\u0131ma eri\u015fimi kolayla\u015ft\u0131rmak \u00fczere faaliyet g\u00f6steren Suudi Arabistan merkezli Abdul Latif Jameel Health, 1,7 milyar insan\u0131 kapsayan geli\u015fmekte olan pazarlarda enflamatuar hastal\u0131klar ve Covid-19 i\u00e7in yeni tedavi \u00fcr\u00fcn aday\u0131n\u0131 geli\u015ftirmek ve ticarile\u015ftirmek i\u00e7in Orta Do\u011fu, T\u00fcrkiye ve Afrika\u2019y\u0131 kapsayan stratejik i\u015f birli\u011fini duyurdu.<\/li>\n<li>Abdul Latif Jameel Health\u2019in ilk biyoteknoloji lisans anla\u015fmas\u0131 olan bu i\u015f birli\u011finin, geli\u015fmekte olan se\u00e7ilmi\u015f pazarlardaki ki\u015filerin Evelo&#8217;nun \u00f6nde gelen enflamasyon ve ilgili sa\u011fl\u0131k otoriteleri taraf\u0131ndan onayland\u0131\u011f\u0131 takdirde kullan\u0131lacak COVID-19 terap\u00f6tik \u00fcr\u00fcn\u00fc aday\u0131 ilaca eri\u015fimini h\u0131zland\u0131rmas\u0131 bekleniyor.<\/li>\n<li>Anla\u015fma, Abdul Latif Jameel Health&#8217;in Orta Do\u011fu, T\u00fcrkiye ve Afrika gibi y\u00fcksek b\u00fcy\u00fcme g\u00f6steren pazarlarda uygun fiyatl\u0131 modern sa\u011fl\u0131k hizmetlerine eri\u015fimi h\u0131zland\u0131rma ve kar\u015f\u0131lanmayan t\u0131bbi bak\u0131m\u0131 ele alma vizyonunu ortaya koyuyor. \u0130mzalanan anla\u015fma Evelo\u2019nun enflamatuar hastal\u0131klardaki liderli\u011fini ve Abdul Latif Jameel\u2019in b\u00f6lgesel da\u011f\u0131t\u0131m uzmanl\u0131\u011f\u0131n\u0131 birle\u015ftirecek.<\/li>\n<\/ul>\n<div style=\"width: 640px;\" class=\"wp-video\"><!--[if lt IE 9]><script>document.createElement('video');<\/script><![endif]-->\n<video class=\"wp-video-shortcode\" id=\"video-86619-1\" width=\"640\" height=\"360\" preload=\"metadata\" controls=\"controls\"><source type=\"video\/mp4\" src=\"https:\/\/www.alj.com\/app\/uploads\/2021\/03\/Abdul-Latif-Jameel-Health-Evelo-Biosciences-Announce-Strategic-Collaboration-TR-16x9-COMP.mp4?_=1\" \/><a href=\"https:\/\/www.alj.com\/app\/uploads\/2021\/03\/Abdul-Latif-Jameel-Health-Evelo-Biosciences-Announce-Strategic-Collaboration-TR-16x9-COMP.mp4\">https:\/\/www.alj.com\/app\/uploads\/2021\/03\/Abdul-Latif-Jameel-Health-Evelo-Biosciences-Announce-Strategic-Collaboration-TR-16x9-COMP.mp4<\/a><\/video><\/div>\n<p>A\u011f\u0131z yoluyla verilen ila\u00e7larda yeni bir y\u00f6ntem geli\u015ftiren bir klinik evre biyoteknoloji \u015firketi olan <a href=\"https:\/\/evelobio.com\/\">Evelo Biosciences<\/a>(Nasdaq: EVLO) ve d\u00fcnya \u00e7ap\u0131nda geli\u015fmekte olan pazarlarda kar\u015f\u0131lanmam\u0131\u015f t\u0131bbi ihtiya\u00e7lar\u0131 ele al\u0131rken uygun fiyatl\u0131 modern t\u0131bbi bak\u0131ma eri\u015fimi h\u0131zland\u0131rmaya odaklanan ve <a href=\"https:\/\/alj.com\/\">Abdul Latif Jameel<\/a>\u2019in bir kolu olan <a href=\"https:\/\/aljhealth.com\/home\/\">Abdul Latif Jameel Health<\/a>, Evelo&#8217;nun \u00f6nde gelen enflamasyon \u00fcr\u00fcn\u00fc aday\u0131 ilac\u0131n\u0131 geli\u015ftirmek ve ticarile\u015ftirmek i\u00e7in Orta Do\u011fu, T\u00fcrkiye ve Afrika\u2019y\u0131 (MENAT b\u00f6lgesi) kapsayan stratejik bir i\u015f birli\u011fi ger\u00e7ekle\u015ftirdikleri duyurdu.<\/p>\n<p>Evelo ve Abdul Latif Jameel Health imzalanan anla\u015fma ile birlikte, geli\u015fmekte olan d\u00fcnyan\u0131n en h\u0131zl\u0131 b\u00fcy\u00fcyen n\u00fcfuslar\u0131nda ve b\u00fcy\u00fcme ekonomilerinde t\u0131bbi bak\u0131ma eri\u015fimdeki \u00f6nemli e\u015fitsizlikleri ele almak amac\u0131yla \u00e7al\u0131\u015facak.<\/p>\n<p><iframe loading=\"lazy\" title=\"Evelo Biosciences\" src=\"https:\/\/player.vimeo.com\/video\/375540993?h=b2d9b789e3&amp;dnt=1&amp;app_id=122963\" width=\"640\" height=\"360\" frameborder=\"0\" allow=\"autoplay; fullscreen; picture-in-picture\" allowfullscreen><\/iframe><\/p>\n<p>\u0130mza t\u00f6reninde, Abdul Latif Jameel Health\u2019in ilk terap\u00f6tik biyoteknoloji i\u015f orta\u011f\u0131 olarak se\u00e7ilmekten onur duyduklar\u0131n\u0131 belirten Evelo \u0130cra Kurulu Ba\u015fkan\u0131 Ph.D <a href=\"https:\/\/evelobio.com\/about\/\">Simba Gill<\/a>,<\/p>\n<blockquote>\n<p>\u201c<em>20 y\u0131l\u0131 a\u015fk\u0131n bir s\u00fcredir Abdul Latif Jameel Health CEO&#8217;su olan <\/em><a href=\"https:\/\/www.alj.com\/en\/our-people\/akram-bouchenaki\/\"><em>Akram Bouchenaki<\/em><\/a><em> ile \u00e7al\u0131\u015fma ayr\u0131cal\u0131\u011f\u0131na sahip oldum. Kendisi, Gilead&#8217;deki g\u00f6revinden bu yana, bu b\u00f6lgede ba\u015far\u0131l\u0131 i\u015fletmeler olu\u015fturma ve geli\u015ftirme konusunda derin bir deneyime sahiptir. Akram&#8217;\u0131n liderli\u011fi, Abdul Latif Jameel&#8217;in Orta Do\u011fu, T\u00fcrkiye ve Afrika&#8217;da sahip oldu\u011fu kapsaml\u0131 da\u011f\u0131t\u0131m uzmanl\u0131\u011f\u0131 ile birle\u015fti\u011finde, bu i\u015f birli\u011fini, y\u00fcz milyonlarca insan i\u00e7in \u00e7ok \u00e7e\u015fitli enflamatuar hastal\u0131klar\u0131 ele almak \u00fczere ila\u00e7lar geli\u015ftirme ve ticarile\u015ftirme hedefimize ula\u015fmam\u0131za yard\u0131mc\u0131 olacak ideal bir i\u015f birli\u011fi haline getiriyor.\u201d<\/em> dedi.<\/p>\n<\/blockquote>\n<p>Orta Do\u011fu, Kuzey Afrika ve T\u00fcrkiye (MENAT b\u00f6lgesi) i\u00e7inde derin k\u00f6klere sahip, \u00e7ok \u00e7e\u015fitli i\u015f kollar\u0131nda faaliyet g\u00f6steren ve 2020&#8217;de <a href=\"https:\/\/jameel75.com\/\">75. y\u0131ld\u00f6n\u00fcm\u00fcn\u00fc<\/a> kutlayan Abdul Latif Jameel bug\u00fcn, alt\u0131 k\u0131tada 30&#8217;dan fazla pazarda faaliyet g\u00f6steren k\u00fcresel bir yat\u0131r\u0131mc\u0131 ve \u00e7e\u015fitlili\u011fe sahip bir \u015firket. Geni\u015f bir b\u00f6lgesel uzmanl\u0131k ve operasyon altyap\u0131s\u0131na sahip olan Abdul Latif Jameel, ihtiyac\u0131 olan herkesin etkili ve uygun fiyatl\u0131 ila\u00e7lara eri\u015fimini h\u0131zland\u0131rma konusunda kararl\u0131 bir duru\u015f sergiliyor.<\/p>\n<figure id=\"attachment_86209\" aria-describedby=\"caption-attachment-86209\" style=\"width: 1038px\" class=\"wp-caption aligncenter\"><img decoding=\"async\" loading=\"lazy\" class=\"size-full wp-image-86209\" src=\"https:\/\/www.alj.com\/app\/uploads\/2021\/03\/Akram-and-Simba-Shake.png\" alt=\"Dr. Akram Bouchenaki, Ph.D. CEO Abdul Latif Jameel Health, (L) and Dr. Simba Gill, Ph.D. CEO Evelo Biosciences (R) at the recent signing ceremony at Abdul Latif Jameel International\u2019s offices in Dubai, UAE.\" width=\"1038\" height=\"693\" srcset=\"https:\/\/media.alj.com\/app\/uploads\/2021\/03\/Akram-and-Simba-Shake.png 1038w, https:\/\/media.alj.com\/app\/uploads\/2021\/03\/Akram-and-Simba-Shake-300x200.png 300w, https:\/\/media.alj.com\/app\/uploads\/2021\/03\/Akram-and-Simba-Shake-1024x684.png 1024w, https:\/\/media.alj.com\/app\/uploads\/2021\/03\/Akram-and-Simba-Shake-150x100.png 150w, https:\/\/media.alj.com\/app\/uploads\/2021\/03\/Akram-and-Simba-Shake-768x513.png 768w\" sizes=\"(max-width: 1038px) 100vw, 1038px\" \/><figcaption id=\"caption-attachment-86209\" class=\"wp-caption-text\">Dr. Akram Bouchenaki, Ph.D. CEO Abdul Latif Jameel Health, (L) and Dr. Simba Gill, Ph.D. CEO Evelo Biosciences (R) at the recent signing ceremony at Abdul Latif Jameel International\u2019s offices in Dubai, UAE.<\/figcaption><\/figure>\n<p>Evelo, Abdul Latif Jameel Health&#8217;in etkili ve uygun fiyatl\u0131 ila\u00e7lar yaratmak i\u00e7in \u00e7al\u0131\u015fan ilk biyoteknoloji i\u015f orta\u011f\u0131 olurken, Abdul Latif Jameel Health, Orta Do\u011fu, T\u00fcrkiye ve Afrika&#8217;da bu vizyonu ger\u00e7ekle\u015ftirmeye yard\u0131mc\u0131 olmak i\u00e7in gereken kritik kaynaklar\u0131 sa\u011flayacak.<\/p>\n<p>Ger\u00e7ekle\u015ftirilen imza t\u00f6reninde, geli\u015fen d\u00fcnyada milyonlarca insana ila\u00e7 g\u00f6t\u00fcrmek i\u00e7in Evelo ile i\u015f birli\u011fi yapmay\u0131 sab\u0131rs\u0131zl\u0131kla beklediklerini belirten Abdul Latif Jameel Health \u0130cra Kurulu Ba\u015fkan\u0131 Akram Bouchenaki,<\/p>\n<blockquote>\n<p><em>\u201cEvelo\u2019nun enflamatuar hastal\u0131klardaki etkili \u00e7al\u0131\u015fmas\u0131, Simba Gill \u00a0ile uzun s\u00fcreli ili\u015fkimizin birle\u015fmesi sayesinde, Evelo&#8217;nun d\u00fcnyan\u0131n en h\u0131zl\u0131 b\u00fcy\u00fcyen b\u00f6lgelerinden baz\u0131lar\u0131nda sa\u011fl\u0131k hizmetlerimizi ba\u015flat\u0131p h\u0131zla b\u00fcy\u00fctmek i\u00e7in do\u011fru i\u015fbirlik\u00e7i oldu\u011funu yeniden teyit ediyor.&#8221;<\/em> dedi.<\/p>\n<\/blockquote>\n<p>Abdul Latif Jameel Ba\u015fkan Vekili ve Y\u00f6netim Kurulu Ba\u015fkan Yard\u0131mc\u0131s\u0131 <a href=\"https:\/\/www.alj.com\/en\/our-people\/fady-jameel\/\">Fady Jameel<\/a> ise imza t\u00f6reninde MIT\u2019de <a href=\"https:\/\/www.jclinic.mit.edu\/\">Jameel Clinic<\/a> ve Imperial College London\u2019da <a href=\"https:\/\/www.imperial.ac.uk\/jameel-institute\/\">Jameel Institute<\/a> kurucular\u0131ndan olan, k\u00fcresel zorluklara bilim ve teknoloji odakl\u0131 \u00e7\u00f6z\u00fcmleri destekleyen uluslararas\u0131 bir organizasyon olan Community Jameel de dahil olmak \u00fczere, Jameel ailesinin daha iyi bir gelecek i\u00e7in inovasyon yapma konusunda uzun s\u00fcredir devam eden taahh\u00fcd\u00fcn\u00fc tekrarlad\u0131.<\/p>\n<p>Sa\u011fl\u0131k hizmetlerine eri\u015fimin, insanlar\u0131n nerede ya\u015fad\u0131\u011f\u0131na veya ekonomik ara\u00e7lar\u0131na bak\u0131lmaks\u0131z\u0131n, t\u0131pk\u0131 su veya bar\u0131nma gibi ink\u00e2r edilemez bir temel insan hakk\u0131 olarak g\u00f6r\u00fclmesi gerekti\u011fini ifade eden Fady<\/p>\n<blockquote>\n<p><em>\u201cZor ve \u00e7ok y\u00f6nl\u00fc bir sorun olmas\u0131na ra\u011fmen, Evelo gibi d\u00fcnya lideri biyoteknoloji uzmanlar\u0131yla \u00e7al\u0131\u015fan Abdul Latif Jameel Health \u00e7\u00f6z\u00fcm\u00fcn bir par\u00e7as\u0131 olmaya kararl\u0131.\u201d \u015feklinde konu\u015ftu.<\/em><\/p>\n<\/blockquote>\n<p>Evelo Bioscienses ve Abdul Latif Jameel Health\u2019in stratejik i\u015f birli\u011fi yapt\u0131\u011f\u0131 enflamatuar hastal\u0131klar\u0131n tedavisi i\u00e7in ara\u015ft\u0131rma ama\u00e7l\u0131 geli\u015ftirilen oral ila\u00e7 olan atopik dermatitte \u00fcr\u00fcn aday\u0131 i\u00e7in, Evelo yak\u0131n zamanda pozitif Faz 1b verileri bildirmi\u015fti. Evelo ayr\u0131ca, sedef hastal\u0131\u011f\u0131nda s\u00f6z konusu \u00fcr\u00fcn aday\u0131 i\u00e7in bir Faz 2 klinik \u00e7al\u0131\u015fman\u0131n yan\u0131 s\u0131ra COVID-19 nedeniyle hastaneye yat\u0131r\u0131lan hastalarda iki \u00e7al\u0131\u015fma y\u00fcr\u00fct\u00fcyor. S\u00f6z konusu \u00fcr\u00fcn aday\u0131n\u0131n Faz 1b klinik \u00e7al\u0131\u015fmalar\u0131ndan elde edilen veriler, enflamatuar hastal\u0131\u011f\u0131n t\u00fcm a\u015famalar\u0131nda hastalar\u0131n tedavisi i\u00e7in g\u00fcvenli, etkili, oral, uygun fiyatl\u0131 ve oda s\u0131cakl\u0131\u011f\u0131nda stabil bir ila\u00e7 olma potansiyelini ortaya koyuyor.<\/p>\n<p>N\u00fcfusu 2030 y\u0131l\u0131na kadar 1,7 milyara ve 2050 y\u0131l\u0131na kadar 2,5 milyara ula\u015fmas\u0131 beklenen Afrika k\u0131tas\u0131na yap\u0131lan y\u0131ll\u0131k harcaman\u0131n 2030 y\u0131l\u0131na kadar 6,66 trilyon ABD dolar\u0131na ula\u015fmas\u0131 beklenirken, sa\u011fl\u0131k hizmetleri dahil olmak \u00fczere sekt\u00f6rlerde b\u00fcy\u00fcyen pazarlar\u0131 te\u015fvik ediyor.<sup>1,2<\/sup><\/p>\n<p>Bununla birlikte, kar\u015f\u0131lanmam\u0131\u015f \u00f6nemli ihtiya\u00e7 devam ederken, belirli alanlarda, se\u00e7ilen ila\u00e7lar\u0131n kullan\u0131labilirli\u011fi baz\u0131 A\u015fa\u011f\u0131 Sahra Afrika \u00fclkeleri i\u00e7in kamuda %21 ve \u00f6zel sekt\u00f6rde %22 gibi d\u00fc\u015f\u00fck oranlarda\u00b2. Benzer \u015fekilde, n\u00fcfusu \u015fu anda 456 milyonun \u00fczerinde olan Orta Do\u011fu ve Kuzey Afrika\u2019da<sup>2<\/sup> sadece Arap b\u00f6lgesindeki n\u00fcfusun ortalama %61\u2019i sa\u011fl\u0131k hizmetlerine kolayca eri\u015febiliyor; ancak bu oran \u00fclkeler aras\u0131nda \u00f6nemli \u00f6l\u00e7\u00fcde farkl\u0131l\u0131k g\u00f6steriyor.<sup>3 <\/sup>\u00a0<\/p>\n<p><span style=\"font-size: 14px;\"><strong>\u0130\u015f birli\u011fi Hakk\u0131nda<\/strong><\/span><\/p>\n<p><span style=\"font-size: 14px;\">Evelo, anla\u015fman\u0131n h\u00fck\u00fcmleri uyar\u0131nca pe\u015fin \u00f6deme ve \u00f6z kaynak yat\u0131r\u0131m\u0131 alm\u0131\u015ft\u0131r. Evelo, EDP1815\u2019in geli\u015ftirilmesinden ve \u00fcretiminden sorumlu olacak, Abdul Latif Jameel Health ise kararla\u015ft\u0131r\u0131lan b\u00f6lgelerde ruhsat ba\u015fvurular\u0131ndan ve ticarile\u015ftirme faaliyetlerinden sorumlu olacakt\u0131r. Evelo ve Abdul Latif Jameel Health 50:50 k\u00e2r pay\u0131 d\u00fczenlemesine kat\u0131lacakt\u0131r.<\/span><\/p>\n<p><span style=\"font-size: 14px;\"><strong>\u0130\u015f birli\u011fine konu \u00fcr\u00fcn aday\u0131 EDP1815 Hakk\u0131nda<\/strong><\/span><\/p>\n<p><span style=\"font-size: 14px;\">EDP1815, enflamatuar hastal\u0131klar\u0131n tedavisi i\u00e7in ara\u015ft\u0131rma ama\u00e7l\u0131 geli\u015ftirilen bir oral ila\u00e7t\u0131r. Bu, oral uygulamadan sonra ba\u011f\u0131rsak s\u0131n\u0131rl\u0131 sal\u0131n\u0131mla sistemik farmakolojik etkiler sa\u011flama potansiyeli i\u00e7in se\u00e7ilmi\u015f bir <em>Prevotella histicola<\/em> su\u015funun canl\u0131 olmayan bir farmas\u00f6tik preparasyonudur. Canl\u0131 olmamas\u0131 nedeniyle ba\u011f\u0131rsaklar\u0131 kolonize etme veya mikrobiyomu modifiye etme g\u00f6zlenmemi\u015ftir. Klinik \u00f6ncesi EDP1815, \u00e7oklu enflamasyon yollar\u0131n\u0131 kapsayan modellerde anti-enflamatuar etkilere sahiptir. Bir Faz 1b klinik \u00e7al\u0131\u015fmas\u0131nda be\u015f ba\u011f\u0131ms\u0131z kohorttan elde edilen klinik sonu\u00e7lar, EDP1815\u2019in Th1, Th2 ve Th17 arac\u0131l\u0131 enflamasyonu ele alma potansiyelini destekleyen kan\u0131tlar sa\u011flamaktad\u0131r.<\/span><\/p>\n<p><span style=\"font-size: 14px;\">EPD1815\u2019in Faz 1b klinik \u00e7al\u0131\u015fmas\u0131n\u0131n sedef hastal\u0131\u011f\u0131 kohortlar\u0131nda, \u00fcr\u00fcn aday\u0131n\u0131n enflamatuar hastal\u0131klar\u0131 olan hastalarda potansiyel olarak zararl\u0131 etkilerin arac\u0131lar\u0131 olan IL-6, IL-8, TNF ve IL-1 dahil olmak \u00fczere \u00e7oklu enflamatuar sitokinlerin sistemik \u00fcretimini s\u0131n\u0131rlad\u0131\u011f\u0131 g\u00f6zlemlenmi\u015ftir. Bug\u00fcne kadar elde edilen klinik \u00f6ncesi ve klinik veriler, EDP1815\u2019in imm\u00fcnos\u00fcpresyona neden olmadan bu anti-enflamatuar aktiviteyi ba\u015fard\u0131\u011f\u0131n\u0131 g\u00f6stermi\u015ftir. Bug\u00fcne kadar yap\u0131lan klinik \u00e7al\u0131\u015fmalarda EDP1815\u2019in genel olarak iyi tolere edildi\u011fi g\u00f6zlenmi\u015ftir.<\/span><\/p>\n<p><span style=\"font-size: 14px;\"><strong>Evelo Biosciences Hakk\u0131nda<\/strong><\/span><\/p>\n<p><span style=\"font-size: 14px;\">Evelo Biosciences, ince ba\u011f\u0131rsak ekseni, SINTAX&#x2122; \u00fczerinde etkili olan ve sistemik terap\u00f6tik etkiler ortaya koyan oral yoldan verilen ila\u00e7lar geli\u015ftiren bir klinik evre biyoteknoloji \u015firketidir. SINTAX imm\u00fcn, metabolik ve n\u00f6rolojik sistemlerin y\u00f6netiminde merkezi bir rol oynar. \u015eirketin ilk \u00fcr\u00fcn adaylar\u0131, tan\u0131mlanm\u0131\u015f farmakolojik \u00f6zellikler i\u00e7in se\u00e7ilen mikroplar\u0131n tek su\u015flar\u0131n\u0131n farmas\u00f6tik preparatlar\u0131d\u0131r.<\/span><\/p>\n<p><span style=\"font-size: 14px;\">Evelo \u015fu anda geli\u015ftirilmekte olan d\u00f6rt \u00fcr\u00fcn aday\u0131na sahiptir: Enflamatuar hastal\u0131klar\u0131n tedavisi i\u00e7in EDP1815, EDP1867 ve EDP2939 ve kanser tedavisi i\u00e7in EDP1908. Evelo di\u011fer hastal\u0131k alanlar\u0131nda ek \u00fcr\u00fcn adaylar\u0131 geli\u015ftirmektedir.<\/span><\/p>\n<p><span style=\"font-size: 14px;\">Daha fazla bilgi i\u00e7in l\u00fctfen <a href=\"http:\/\/www.evelobio.com\">www.evelobio.com<\/a> adresini ziyaret edin ve <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=V0MqNoDHC-DFVYYv2UNnkg2C4w0tB2Abm4NCPwUX5T9JDyclAm_kh7wHWcu6QKux4b1HFYQGSq4gCRVU1zDAHKVg4LN3VNGXJBUU72tXy7-qDOyyiXeqBLy71oZpV8IH\">LinkedIn<\/a> ve <a href=\"https:\/\/www.youtube.com\/watch?v=3yqWQADYOck\">video<\/a> \u00fczerinden Evelo ile ileti\u015fime ge\u00e7in.<\/span><br \/>\n<span style=\"font-size: 14px;\">\u0130leti\u015fim Bilgisi: Jessica Cotrone, +1-978-760-5622, <a href=\"mailto:jcotrone@evelobio.com\">jcotrone@evelobio.com<\/a><\/span><\/p>\n<p><span style=\"font-size: 14px;\"><strong>Abdul Latif Jameel Health hakk\u0131nda<\/strong><\/span><\/p>\n<p><span style=\"font-size: 14px;\">75 y\u0131ll\u0131k bir mirasa, derin k\u00f6klere ve alt\u0131 k\u0131taya yay\u0131lm\u0131\u015f 30 \u00fclkede \u00e7ok sekt\u00f6rl\u00fc bir varl\u0131\u011f\u0131n yan\u0131 s\u0131ra yerle\u015fik a\u011flara sahip en sayg\u0131n aile \u015firketlerinden ve yat\u0131r\u0131mc\u0131lardan biri olan <a href=\"https:\/\/alj.com\/\">Abdul Latif Jameel<\/a> taraf\u0131ndan desteklenen Abdul Latif Jameel Health, sa\u011fl\u0131k hizmetleri d\u00fcnyas\u0131nda b\u00fcy\u00fck yenilikler ve f\u0131rsatlar yaratmada benzersiz bir g\u00fcvenilir ortak olarak konumlanm\u0131\u015ft\u0131r.<\/span><\/p>\n<p><span style=\"font-size: 14px;\"><a href=\"https:\/\/aljhealth.com\">Abdul Latif Jameel Health<\/a>, Jameel ailesinin daha iyi bir gelecek i\u00e7in inovasyon yapma konusundaki k\u00f6kl\u00fc taahh\u00fcd\u00fcn\u00fc, k\u00fcresel zorluklar i\u00e7in bilim ve teknoloji odakl\u0131 \u00e7\u00f6z\u00fcmleri destekleyen uluslararas\u0131 bir organizasyon olan <a href=\"https:\/\/www.communityjameel.org\/en\">Community Jameel<\/a> arac\u0131l\u0131\u011f\u0131yla yans\u0131tmaktad\u0131r. Community Jameel,<a href=\"https:\/\/mit.edu\"> MIT<\/a> ile birlikte <a href=\"https:\/\/www.alj.com\/en\/news\/abdul-latif-jameel-clinic-machine-learning-health-mit-aims-revolutionize-disease-prevention-detection-treatment\/\">Eyl\u00fcl 2018<\/a>\u2019de &#8211; <a href=\"https:\/\/www.alj.com\/en\/news\/j-clinic-discovers-powerful-new-antibiotic-using-ai-technology\/\">MIT&#8217;de k\u0131sa s\u00fcrede yapay zeka ve sa\u011fl\u0131k hizmetlerinin merkez \u00fcss\u00fc<\/a> haline gelen &#8211; Sa\u011fl\u0131kta Makine \u00d6\u011frenimi i\u00e7in Abdul Latif Jameel Klini\u011fini (<a href=\"https:\/\/www.jclinic.mit.edu\/\">Jameel Clinic<\/a>) kurdu, ve <a href=\"https:\/\/www.alj.com\/en\/news\/rapid-response-research-centre-to-predict-and-prevent-global-health-crises\/\">Ekim 2019<\/a>\u2019da <a href=\"https:\/\/www.imperial.ac.uk\/\">Imperial College London<\/a> ile birlikte en son 2020 COVID-19 salg\u0131n\u0131 da dahil olmak \u00fczere \u00f6nlenebilir hastal\u0131klar\u0131n k\u00fcresel riskini yeni veri analizleri kullanarak azaltmak ve en k\u0131r\u0131lgan ortamlarda sa\u011fl\u0131k sistemlerini g\u00fc\u00e7lendirmek i\u00e7in Abdul Latif Jameel Hastal\u0131k ve Acil Durum Analiti\u011fi Enstit\u00fcs\u00fc\u2019n\u00fc (<a href=\"https:\/\/www.imperial.ac.uk\/jameel-institute\">Jameel Institute<\/a>) kurdu.<\/span><\/p>\n<p><span style=\"font-size: 14px;\">Abdul Latif Jameel Health, bu taahh\u00fcd\u00fc, daha iyi bir yar\u0131n i\u00e7in bug\u00fcn\u00fcn somut ger\u00e7ek d\u00fcnya ihtiya\u00e7lar\u0131n\u0131 ele alan ticari ortama ta\u015f\u0131maktad\u0131r. Mevcut \u00e7\u00f6z\u00fcmlerin da\u011f\u0131t\u0131lmas\u0131 i\u00e7in yeni pazarlar a\u00e7arak \/ b\u00fcy\u00fcterek ve MedTech&#8217;in gelece\u011fine yat\u0131r\u0131m yaparak en \u00e7ok ihtiya\u00e7 duyanlar i\u00e7in modern t\u0131bbi bak\u0131ma eri\u015fimi h\u0131zland\u0131racak \u015fekilde, k\u00fcresel g\u00fcneyde sa\u011fl\u0131k hizmetlerinin dahil edilmesine odaklanm\u0131\u015ft\u0131r.<\/span><\/p>\n<p><span style=\"font-size: 14px;\"><a href=\"https:\/\/alj.com\">Abdul Latif Jameel<\/a>, FinTech, InsurTech, elektrikli ara\u00e7lar ve gelecekteki mobilite \u00e7\u00f6z\u00fcmleri gibi geli\u015fmekte olan teknolojilerin yan\u0131 s\u0131ra, ila\u00e7 ve a\u015f\u0131lardan en son t\u0131bbi teknolojiye kadar t\u0131p ve sa\u011fl\u0131k hizmetleri sekt\u00f6rlerini kapsayan yat\u0131r\u0131mlar\u0131yla k\u00fcresel ekonomiye y\u00f6n veren temel end\u00fcstrilerin gelece\u011fini olumlu \u015fekillendirmeyi ama\u00e7layan yenilik\u00e7i, erken a\u015fama ve \u00e7\u0131\u011f\u0131r a\u00e7an giri\u015fimlere ve teknolojiye aktif olarak yat\u0131r\u0131m yapmaktad\u0131r.<\/span><\/p>\n<p><span style=\"font-size: 14px;\">Daha fazla bilgi i\u00e7in <a href=\"https:\/\/aljhealth.com\">https:\/\/aljhealth.com<\/a> sitesini ziyaret edin ve marka videomuzu <a href=\"https:\/\/youtu.be\/k7mRvkh18Ts\">buradan<\/a> izleyin.<\/span><br \/>\n<span style=\"font-size: 14px;\">Medya \u0130leti\u015fimi: <u>aljhealth@edelman.com<\/u> adresine e-posta g\u00f6nderin veya \u015fu telefonu aray\u0131n: +971 54 996 9935 (GMT +4 saat BAE)<\/span><\/p>\n<p><span style=\"font-size: 14px;\"><strong>Abdul Latif Jameel Hakk\u0131nda<\/strong><\/span><\/p>\n<p><span style=\"font-size: 14px;\">Abdul Latif Jameel, k\u00fcresel bir yat\u0131r\u0131mc\u0131d\u0131r ve 2020 y\u0131l\u0131nda 75. y\u0131ld\u00f6n\u00fcm\u00fcn\u00fc kutlayan \u00e7ok y\u00f6nl\u00fc, \u00f6zel bir aile k\u00f6kenli \u015firkettir. Binek ara\u00e7lar, ticari ara\u00e7lar ve ekipman, lojistik, m\u00fchendislik ve \u00fcretim, finansal hizmetler, enerji ve \u00e7evre hizmetleri, sa\u011fl\u0131k, arazi ve gayrimenkul, t\u00fcketici \u00fcr\u00fcnleri ve reklam ve medya dahil olmak \u00fczere bir dizi b\u00fcy\u00fck end\u00fcstri sekt\u00f6r\u00fcndeki bir\u00e7ok ba\u011f\u0131ms\u0131z kurulu\u015ftan olu\u015fur. G\u00fc\u00e7l\u00fc g\u00fcvenilir a\u011flar ve uzun s\u00fcreli ili\u015fkiler, Abdul Latif Jameel&#8217;i t\u00fcm d\u00fcnyada g\u00fc\u00e7l\u00fc bir i\u015f ve yat\u0131r\u0131m orta\u011f\u0131 haline getirmektedir. \u015eu anda alt\u0131 k\u0131tada 30&#8217;dan fazla \u00fclkede varl\u0131k g\u00f6stermektedir ve 40&#8217;tan fazla milletten, 11.000&#8217;den fazla ki\u015fi istihdam etmektedir.<\/span><\/p>\n<p><span style=\"font-size: 14px;\">Daha fazla bilgi i\u00e7in \u015fu adresi ziyaret edin: <a href=\"https:\/\/aljhealth.com\">https:\/\/aljhealth.com<\/a>.<\/span><\/p>\n<p><span style=\"font-size: 14px;\">Bas\u0131n sorular\u0131 i\u00e7in media@alj.ae ile ileti\u015fime ge\u00e7in veya +971 4 448 0906 (GMT +4 saat BAE) numaral\u0131 telefonu aray\u0131n<\/span><\/p>\n<p><span style=\"font-size: 14px;\"><strong>\u0130leriye D\u00f6n\u00fck A\u00e7\u0131klamalar<\/strong><\/span><\/p>\n<p><span style=\"font-size: 14px;\">Bu bas\u0131n a\u00e7\u0131klamas\u0131 1995 tarihli \u00d6zel Menkul K\u0131ymetler Dava Reform Yasas\u0131 kapsam\u0131nda ileriye d\u00f6n\u00fck beyanlar i\u00e7ermektedir. Bu bas\u0131n a\u00e7\u0131klamas\u0131nda yer alan ve ge\u00e7mi\u015f olgulara dair konularla ilgili olmayan t\u00fcm beyanlar, EDP1815 i\u00e7in klinik ara\u015ft\u0131rmalar\u0131n veya okumalar\u0131n sonu\u00e7lar\u0131, geli\u015fim planlar\u0131m\u0131z ve \u00fcr\u00fcn adaylar\u0131m\u0131z\u0131n vaadi ve potansiyel etkisi ile ilgili beyanlar da dahil olmak \u00fczere ileriye d\u00f6n\u00fck beyanlar olarak de\u011ferlendirilmelidir. <\/span><\/p>\n<p><span style=\"font-size: 14px;\">Bu ileriye d\u00f6n\u00fck beyanlar y\u00f6netimin mevcut beklentilerine dayanmaktad\u0131r. Bu beyanlar vaat veya taahh\u00fct de\u011fildir, ancak ger\u00e7ek sonu\u00e7lar\u0131m\u0131z\u0131n, performans\u0131m\u0131z\u0131n veya ba\u015far\u0131lar\u0131m\u0131z\u0131n ileriye d\u00f6n\u00fck ifade veya ima edilen gelecekteki sonu\u00e7lardan, performanslardan veya ba\u015far\u0131lardan maddi olarak farkl\u0131 olmas\u0131na neden olabilecek bilinen ve bilinmeyen riskleri, belirsizlikleri ve di\u011fer \u00f6nemli fakt\u00f6rleri i\u00e7erir; bu fakt\u00f6rlere a\u015fa\u011f\u0131da belirtilenler dahildir, ancak bunlarla s\u0131n\u0131rl\u0131 de\u011fildir: COVID-19 salg\u0131n\u0131n\u0131n klinik \u00f6ncesi \u00e7al\u0131\u015fmalar\u0131m\u0131z ve klinik denemelerimiz dahil operasyonlar\u0131m\u0131z \u00fczerindeki etkisi ve i\u015fimizin devaml\u0131l\u0131\u011f\u0131; \u00f6nemli zararlara u\u011frad\u0131k, \u015fu anda k\u00e2rda de\u011filiz ve asla k\u00e2rda olamayabiliriz; ek finansman ihtiyac\u0131m\u0131z; s\u0131n\u0131rl\u0131 \u00e7al\u0131\u015fma ge\u00e7mi\u015fimiz; terap\u00f6tik m\u00fcdahaleye y\u00f6nelik kan\u0131tlanmam\u0131\u015f yakla\u015f\u0131m\u0131m\u0131z; d\u00fczenleyici makam onay\u0131ndaki olas\u0131 gecikmeler dahil, uzun, pahal\u0131 ve belirsiz klinik ila\u00e7 geli\u015ftirme s\u00fcreci; mikrobiyal k\u00fct\u00fcphanemizi geni\u015fletmek, klinik deneylerimizi y\u00fcr\u00fctmek, \u00fcr\u00fcn adaylar\u0131m\u0131z\u0131 \u00fcretmek ve onaylan\u0131rsa \u00fcr\u00fcn adaylar\u0131m\u0131z\u0131 geli\u015ftirmek ve ticarile\u015ftirmek i\u00e7in \u00fc\u00e7\u00fcnc\u00fc taraflara ve i\u015fbirlik\u00e7ilerine olan g\u00fcvenimiz; \u00fcr\u00fcn adaylar\u0131m\u0131z\u0131n imalat, sat\u0131\u015f, pazarlama ve da\u011f\u0131t\u0131m\u0131ndaki deneyim eksikli\u011fimiz; di\u011fer ila\u00e7 \u015firketleriyle ba\u015far\u0131l\u0131 bir \u015fekilde rekabet edememe; tescilli teknolojimizin ve ticari s\u0131rlar\u0131m\u0131z\u0131n gizlili\u011finin korunmas\u0131; \u00fc\u00e7\u00fcnc\u00fc \u015fah\u0131s fikri m\u00fclkiyet haklar\u0131n\u0131n ihlali i\u00e7in olas\u0131 davalar veya iddialar veya bizim fikri m\u00fclkiyet hakk\u0131m\u0131za y\u00f6nelik itirazlar; patentlerimizin ge\u00e7ersiz veya uygulanamaz bulunmas\u0131; uluslararas\u0131 operasyonlarla ili\u015fkili riskler; kilit personeli elde tutma ve b\u00fcy\u00fcmemizi y\u00f6netme becerimiz; adi hisse senetlerimizin potansiyel oynakl\u0131\u011f\u0131; y\u00f6netimimiz ve ana hissedarlar\u0131m\u0131z i\u015fimizi kontrol etme veya \u00f6nemli \u00f6l\u00e7\u00fcde etkileme becerisine sahiptir; halka a\u00e7\u0131k bir \u015firket olarak faaliyet g\u00f6stermenin maliyetleri ve kaynaklar\u0131; olumsuz veya hi\u00e7 olmayan analist ara\u015ft\u0131rmas\u0131 veya raporu; ve bize kar\u015f\u0131 menkul k\u0131ymetler s\u0131n\u0131f\u0131 faaliyet davas\u0131.<\/span><\/p>\n<p><iframe loading=\"lazy\" title=\"Abdul Latif Jameel Health Brand Video (EN+EN Subtitles 16x9 FINAL)\" width=\"640\" height=\"360\" src=\"https:\/\/www.youtube.com\/embed\/T6q1Njfn5LE?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" allowfullscreen><\/iframe><\/p>\n<p><span style=\"font-size: 14px;\">Bunlar ve 31 Aral\u0131k 2020\u2019de sona eren mali y\u0131l i\u00e7in Form 10-K Y\u0131ll\u0131k Raporumuzda \u201cRisk Fakt\u00f6rleri\u201d ba\u015fl\u0131\u011f\u0131 alt\u0131nda ele al\u0131nan di\u011fer \u00f6nemli fakt\u00f6rler ve SEC\u2019e sunulan di\u011fer raporlar\u0131m\u0131z, ger\u00e7ek sonu\u00e7lar\u0131n bu bas\u0131n a\u00e7\u0131klamas\u0131nda yap\u0131lan ileriye d\u00f6n\u00fck beyanlarda belirtilenlerden \u00f6nemli \u00f6l\u00e7\u00fcde farkl\u0131 olmas\u0131na neden olabilir. Bu t\u00fcr ileriye d\u00f6n\u00fck beyanlar, bu bas\u0131n a\u00e7\u0131klamas\u0131n\u0131n tarihi itibariyle y\u00f6netimin tahminlerini temsil eder. Bu t\u00fcr ileriye d\u00f6n\u00fck beyanlar\u0131, yasalar\u0131n gerektirdi\u011fi durumlar d\u0131\u015f\u0131nda, gelecekte herhangi bir noktada g\u00fcncellemeyi tercih edebilecek olsak da, sonraki olaylar g\u00f6r\u00fc\u015flerimizin de\u011fi\u015fmesine neden olsa bile bu t\u00fcr beyanlar\u0131 yapma zorunlulu\u011funu reddediyoruz. Bu ileriye d\u00f6n\u00fck beyanlar\u0131n, bu bas\u0131n b\u00fclteninin tarihinden sonraki herhangi bir tarihten itibaren g\u00f6r\u00fc\u015flerimizi temsil etti\u011fi d\u00fc\u015f\u00fcn\u00fclmemelidir. <\/span><\/p>\n<p><span style=\"font-size: 12px;\"><a href=\"#_ftnref1\" name=\"_ftn1\">[1]<\/a> A. Leke and L. Sign\u00e9, \u201cSpotlighting opportunities for business in Africa and strategies to succeed in the world\u2019s next big growth market,\u201d Brookings, Feb. 11, 2019,\u00a0<\/span><span style=\"font-size: 12px;\"><a href=\"https:\/\/www.brookings.edu\/research\/spotlighting-opportunities-for-business-in-africa-and-strategies-to-succeed-in-the-worlds-next-big-growth-market\/.%20%20\">https:\/\/www.brookings.edu\/research\/spotlighting-opportunities-for-business-in-africa-and-strategies-to-succeed-in-the-worlds-next-big-growth-market\/. <\/a>\u00a0<\/span><span style=\"font-size: 12px;\">UHC in Africa: A Framework for Action,\u201d World Bank and World Health Organization. <a href=\"https:\/\/www.worldbank.org\/en\/topic\/universalhealthcoverage\/publication\/universal-health-coverage-in-africa-a-framework-for-action\">https:\/\/www.worldbank.org\/en\/topic\/universalhealthcoverage\/publication\/universal-health-coverage-in-africa-a-framework-for-action<\/a><\/span><\/p>\n<p><span style=\"font-size: 12px;\"><a href=\"#_ftnref2\" name=\"_ftn2\">[2]<\/a> \u201cPopulation Total \u2013 MENA,\u201d The World Bank, <a href=\"https:\/\/data.worldbank.org\/indicator\/SP.POP.TOTL?locations=ZQ&amp;name_desc=false\">https:\/\/data.worldbank.org\/indicator\/SP.POP.TOTL?locations=ZQ&amp;name_desc=false<\/a>.\u00a0\u00a0<\/span><\/p>\n<p><span style=\"font-size: 12px;\"><a href=\"#_ftnref3\" name=\"_ftn3\">[3]<\/a> \u201cPolicy Brief: The Impact of COVID-19 on the Arab Region, An Opportunity to Build Back Better,\u201d United Nations, July 2020. <a href=\"https:\/\/data.worldbank.org\/indicator\/SP.POP.TOTL?locations=ZQ&amp;name_desc=false\">https:\/\/data.worldbank.org\/indicator\/SP.POP.TOTL?locations=ZQ&amp;name_desc=false<\/a>.\u00a0\u00a0<\/span><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"featured_media":86390,"template":"","tags":[],"newscategory":[149],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Yeni Terapi EDP1815&#039;in Geli\u015ftirilmesi | Abdul Latif Jameel\u00ae<\/title>\n<meta name=\"description\" content=\"Evelo Biosciences ve Abdul Latif Jameel Health, Orta Do\u011fu, T\u00fcrkiye ve Afrika&#039;da yeni terapi EDP1815&#039;i geli\u015ftirmek ve ticarile\u015ftirmek i\u00e7in stratejik i\u015fbirli\u011fini duyurdu.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/alj.com\/tr\/news\/evelo-biosciences-abdul-latif-jameel-health-announce-strategic-collaboration-to-develop-commercialize-novel-therapy-edp1815-for-inflammatory-diseases-covid-19-in-select-developing-markets-servin\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Yeni Terapi EDP1815&#039;in Geli\u015ftirilmesi | Abdul Latif Jameel\u00ae\" \/>\n<meta property=\"og:description\" content=\"Evelo Biosciences ve Abdul Latif Jameel Health, Orta Do\u011fu, T\u00fcrkiye ve Afrika&#039;da yeni terapi EDP1815&#039;i geli\u015ftirmek ve ticarile\u015ftirmek i\u00e7in stratejik i\u015fbirli\u011fini duyurdu.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/alj.com\/tr\/news\/evelo-biosciences-abdul-latif-jameel-health-announce-strategic-collaboration-to-develop-commercialize-novel-therapy-edp1815-for-inflammatory-diseases-covid-19-in-select-developing-markets-servin\/\" \/>\n<meta property=\"og:site_name\" content=\"Abdul Latif Jameel\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Abdul.Latif.Jameel.Official\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-28T09:07:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/media.alj.com\/app\/uploads\/2021\/03\/ALJ_Health-Evelo-WEBSITE.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1271\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"15 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/alj.com\/tr\/news\/evelo-biosciences-abdul-latif-jameel-health-announce-strategic-collaboration-to-develop-commercialize-novel-therapy-edp1815-for-inflammatory-diseases-covid-19-in-select-developing-markets-servin\/\",\"url\":\"https:\/\/alj.com\/tr\/news\/evelo-biosciences-abdul-latif-jameel-health-announce-strategic-collaboration-to-develop-commercialize-novel-therapy-edp1815-for-inflammatory-diseases-covid-19-in-select-developing-markets-servin\/\",\"name\":\"Yeni Terapi EDP1815'in Geli\u015ftirilmesi | Abdul Latif Jameel\u00ae\",\"isPartOf\":{\"@id\":\"https:\/\/alj.com\/en\/#website\"},\"datePublished\":\"2021-03-23T06:56:49+00:00\",\"dateModified\":\"2023-03-28T09:07:04+00:00\",\"description\":\"Evelo Biosciences ve Abdul Latif Jameel Health, Orta Do\u011fu, T\u00fcrkiye ve Afrika'da yeni terapi EDP1815'i geli\u015ftirmek ve ticarile\u015ftirmek i\u00e7in stratejik i\u015fbirli\u011fini duyurdu.\",\"breadcrumb\":{\"@id\":\"https:\/\/alj.com\/tr\/news\/evelo-biosciences-abdul-latif-jameel-health-announce-strategic-collaboration-to-develop-commercialize-novel-therapy-edp1815-for-inflammatory-diseases-covid-19-in-select-developing-markets-servin\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/alj.com\/tr\/news\/evelo-biosciences-abdul-latif-jameel-health-announce-strategic-collaboration-to-develop-commercialize-novel-therapy-edp1815-for-inflammatory-diseases-covid-19-in-select-developing-markets-servin\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/alj.com\/tr\/news\/evelo-biosciences-abdul-latif-jameel-health-announce-strategic-collaboration-to-develop-commercialize-novel-therapy-edp1815-for-inflammatory-diseases-covid-19-in-select-developing-markets-servin\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/alj.com\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\/\/alj.com\/ar\/news\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Evelo Biosciences ve Abdul Latif Jameel Health\u2019ten 1,7 Milyar \u0130nsana Hizmet Eden Orta Do\u011fu, T\u00fcrkiye ve Afrika Pazarlar\u0131nda Enflamatuar Hastal\u0131klar ve COVID-19 i\u00e7in Stratejik \u0130\u015f birli\u011fi\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/alj.com\/en\/#website\",\"url\":\"https:\/\/alj.com\/en\/\",\"name\":\"Abdul Latif Jameel\",\"description\":\"Abdul Latif Jameel\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/alj.com\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"tr\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Yeni Terapi EDP1815'in Geli\u015ftirilmesi | Abdul Latif Jameel\u00ae","description":"Evelo Biosciences ve Abdul Latif Jameel Health, Orta Do\u011fu, T\u00fcrkiye ve Afrika'da yeni terapi EDP1815'i geli\u015ftirmek ve ticarile\u015ftirmek i\u00e7in stratejik i\u015fbirli\u011fini duyurdu.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/alj.com\/tr\/news\/evelo-biosciences-abdul-latif-jameel-health-announce-strategic-collaboration-to-develop-commercialize-novel-therapy-edp1815-for-inflammatory-diseases-covid-19-in-select-developing-markets-servin\/","og_locale":"tr_TR","og_type":"article","og_title":"Yeni Terapi EDP1815'in Geli\u015ftirilmesi | Abdul Latif Jameel\u00ae","og_description":"Evelo Biosciences ve Abdul Latif Jameel Health, Orta Do\u011fu, T\u00fcrkiye ve Afrika'da yeni terapi EDP1815'i geli\u015ftirmek ve ticarile\u015ftirmek i\u00e7in stratejik i\u015fbirli\u011fini duyurdu.","og_url":"https:\/\/alj.com\/tr\/news\/evelo-biosciences-abdul-latif-jameel-health-announce-strategic-collaboration-to-develop-commercialize-novel-therapy-edp1815-for-inflammatory-diseases-covid-19-in-select-developing-markets-servin\/","og_site_name":"Abdul Latif Jameel","article_publisher":"https:\/\/www.facebook.com\/Abdul.Latif.Jameel.Official","article_modified_time":"2023-03-28T09:07:04+00:00","og_image":[{"width":2560,"height":1271,"url":"https:\/\/media.alj.com\/app\/uploads\/2021\/03\/ALJ_Health-Evelo-WEBSITE.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"15 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/alj.com\/tr\/news\/evelo-biosciences-abdul-latif-jameel-health-announce-strategic-collaboration-to-develop-commercialize-novel-therapy-edp1815-for-inflammatory-diseases-covid-19-in-select-developing-markets-servin\/","url":"https:\/\/alj.com\/tr\/news\/evelo-biosciences-abdul-latif-jameel-health-announce-strategic-collaboration-to-develop-commercialize-novel-therapy-edp1815-for-inflammatory-diseases-covid-19-in-select-developing-markets-servin\/","name":"Yeni Terapi EDP1815'in Geli\u015ftirilmesi | Abdul Latif Jameel\u00ae","isPartOf":{"@id":"https:\/\/alj.com\/en\/#website"},"datePublished":"2021-03-23T06:56:49+00:00","dateModified":"2023-03-28T09:07:04+00:00","description":"Evelo Biosciences ve Abdul Latif Jameel Health, Orta Do\u011fu, T\u00fcrkiye ve Afrika'da yeni terapi EDP1815'i geli\u015ftirmek ve ticarile\u015ftirmek i\u00e7in stratejik i\u015fbirli\u011fini duyurdu.","breadcrumb":{"@id":"https:\/\/alj.com\/tr\/news\/evelo-biosciences-abdul-latif-jameel-health-announce-strategic-collaboration-to-develop-commercialize-novel-therapy-edp1815-for-inflammatory-diseases-covid-19-in-select-developing-markets-servin\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/alj.com\/tr\/news\/evelo-biosciences-abdul-latif-jameel-health-announce-strategic-collaboration-to-develop-commercialize-novel-therapy-edp1815-for-inflammatory-diseases-covid-19-in-select-developing-markets-servin\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/alj.com\/tr\/news\/evelo-biosciences-abdul-latif-jameel-health-announce-strategic-collaboration-to-develop-commercialize-novel-therapy-edp1815-for-inflammatory-diseases-covid-19-in-select-developing-markets-servin\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/alj.com\/tr\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/alj.com\/ar\/news\/"},{"@type":"ListItem","position":3,"name":"Evelo Biosciences ve Abdul Latif Jameel Health\u2019ten 1,7 Milyar \u0130nsana Hizmet Eden Orta Do\u011fu, T\u00fcrkiye ve Afrika Pazarlar\u0131nda Enflamatuar Hastal\u0131klar ve COVID-19 i\u00e7in Stratejik \u0130\u015f birli\u011fi"}]},{"@type":"WebSite","@id":"https:\/\/alj.com\/en\/#website","url":"https:\/\/alj.com\/en\/","name":"Abdul Latif Jameel","description":"Abdul Latif Jameel","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/alj.com\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"tr"}]}},"post-meta-fields":{"_alp_processed":["1616580414"],"_wpml_word_count":["{\"total\":2347,\"to_translate\":{\"ar\":2347,\"zh-hans\":2347,\"fr\":2347,\"ja\":2347,\"es\":2347,\"tr\":2347}}"],"push_notification":["no"],"_push_notification":["field_5c3b1fb67034d"],"_wpml_media_featured":["1"],"_wpml_media_duplicate":["1"],"_oembed_946a45d80b377aac7ed59e1fca269733":["<iframe title=\"Abdul Latif Jameel Health Brand Video (EN+EN Subtitles 16x9 FINAL)\" width=\"640\" height=\"360\" src=\"https:\/\/www.youtube.com\/embed\/T6q1Njfn5LE?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" allowfullscreen><\/iframe>"],"_oembed_time_946a45d80b377aac7ed59e1fca269733":["1679994439"],"_oembed_c390980aff06b40f98a19570a1b0e141":["<iframe title=\"Evelo Biosciences\" src=\"https:\/\/player.vimeo.com\/video\/375540993?h=b2d9b789e3&amp;dnt=1&amp;app_id=122963\" width=\"640\" height=\"360\" frameborder=\"0\" allow=\"autoplay; fullscreen; picture-in-picture\" allowfullscreen><\/iframe>"],"_oembed_time_c390980aff06b40f98a19570a1b0e141":["1679994439"],"news_summary":["<p>Evelo Biosciences ve Abdul Latif Jameel Health, enflamatuar hastal\u0131klar ve COVID-19 i\u00e7in yeni tedavi geli\u015ftirmek i\u00e7in stratejik i\u015fbirli\u011fi imzalad\u0131<\/p>\n"],"wpcf-featured-news":["1"],"publish_mobile":[""],"_publish_mobile":["field_5bfa8eb2e65cf"],"mobile_featured_image":["https:\/\/media.alj.com\/app\/uploads\/2021\/03\/ALJ_Health_EVOLO_Image_128-scaled.jpg"],"_mobile_featured_image":["field_5c3b204983dea"],"_yoast_wpseo_primary_newscategory":["149"],"_bsf_post_type":["0"],"_bsf_item_review_type":["none"],"_yoast_wpseo_title":["Yeni Terapi EDP1815'in Geli\u015ftirilmesi | Abdul Latif Jameel\u00ae"],"_yoast_wpseo_metadesc":["Evelo Biosciences ve Abdul Latif Jameel Health, Orta Do\u011fu, T\u00fcrkiye ve Afrika'da yeni terapi EDP1815'i geli\u015ftirmek ve ticarile\u015ftirmek i\u00e7in stratejik i\u015fbirli\u011fini duyurdu."],"_yoast_wpseo_content_score":["30"],"post_views_count_2021Mar":["59"],"news_slider_short_title":["Enflamatuar hastal\u0131k ve COVID19 terap\u00f6tik geli\u015ftirmek i\u00e7in stratejik i\u015fbirli\u011fi"],"_thumbnail_id":["86390"],"_last_translation_edit_mode":["native-editor"],"post_views_count_2021Apr":["23"],"post_views_count_2021May":["15"],"post_views_count_2021Jun":["5"],"wpcf-show-at-homepage-first-sec-secondary-slider":["1"],"wpcf-news-publish_date":["1616457600"],"post_views_count_2021Jul":["13"],"post_views_total_count":["13"],"_edit_lock":["1679994304:21"],"_edit_last":["21"],"news_business_sector":["Sa\u011fl\u0131k"],"wpcf-featured-on-news-page":["0"],"featured_on_listing_page":["0"],"_featured_on_listing_page":["field_62458ea7383c3"],"content_series_applied":[""],"_content_series_applied":["field_60f3d3faf82ac"],"wpcf-card-image":[""],"_wpcf-card-image-sort-order":["a:1:{i:0;i:1461090;}"],"wpcf-news-downloadable_file":[""],"wpcf-projecttitle":[""],"wpcf-projectdescription":[""],"wpcf-projectimage-video1":["image"],"wpcf-projectimage-1":[""],"wpcf-projectvideo-1":[""],"wpcf-projectdescription-1":[""],"wpcf-projectimage-video2":["image"],"wpcf-projectimage-2":[""],"wpcf-projectvideo-2":[""],"wpcf-projectdescription-2":[""],"wpcf-projectimage-video3":["image"],"wpcf-projectimage-3":[""],"wpcf-projectvideo-3":[""],"wpcf-projectdescription-3":[""],"wpcf-projectimage-video4":["image"],"wpcf-projectimage-4":[""],"wpcf-projectvideo-4":[""],"wpcf-projectdescription-4":[""],"wpcf-video-description":[""],"wpcf-layoutvideourl":[""],"wpcf-video-thumb":[""],"wpcf-social4-svg":[""],"wpcf-social4-background-image":[""],"wpcf-social4-text":[""],"wpcf-social4-url":[""],"wpcf-social3-svg":[""],"wpcf-social3-background-image":[""],"wpcf-social3-text":[""],"wpcf-social3-url":[""],"wpcf-social-text-svg-square":[""],"wpcf-social-text-image-square":[""],"wpcf-social-text-text-square":[""],"wpcf-social-text-url-square":[""],"wpcf-social2-svg":[""],"wpcf-social2-background-image":[""],"wpcf-social2-text":[""],"wpcf-social2-url":[""],"wpcf-social-svg-square":[""],"wpcf-social-image-square":[""],"wpcf-social-text-square":[""],"wpcf-social-url-square":[""],"wpcf-social1-svg":[""],"wpcf-social1-background-image":[""],"wpcf-social1-text":[""],"wpcf-social1-url":[""],"wpcf-quotes-with-auther-text-1":[""],"wpcf-card_article_with_title_content":[""],"wpcf-card_article_content":["write your content"],"wpcf-quotes-with-auther-text":[""],"_yoast_wpseo_estimated-reading-time-minutes":[""],"_yoast_wpseo_canonical":["https:\/\/alj.com\/tr\/news\/evelo-biosciences-abdul-latif-jameel-health-announce-strategic-collaboration-to-develop-commercialize-novel-therapy-edp1815-for-inflammatory-diseases-covid-19-in-select-developing-markets-servin\/"],"_yoast_wpseo_wordproof_timestamp":[""]},"_links":{"self":[{"href":"https:\/\/alj.com\/tr\/wp-json\/wp\/v2\/news\/86619"}],"collection":[{"href":"https:\/\/alj.com\/tr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/alj.com\/tr\/wp-json\/wp\/v2\/types\/news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alj.com\/tr\/wp-json\/wp\/v2\/media\/86390"}],"wp:attachment":[{"href":"https:\/\/alj.com\/tr\/wp-json\/wp\/v2\/media?parent=86619"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alj.com\/tr\/wp-json\/wp\/v2\/tags?post=86619"},{"taxonomy":"newscategory","embeddable":true,"href":"https:\/\/alj.com\/tr\/wp-json\/wp\/v2\/newscategory?post=86619"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}